CoChat

MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer

Open access
Chen, Wei-Yu, Liu, Shih-Yang, Chang, Yung-Sheng, Juan Yin, Juan, Yeh, Hsiu-lien, Mouhieddine, Tarek H., Hadadeh, Ola, Abou-Kheir, Wassim, Liu, Yen-Nien · 2015 · Oncotarget
Cited by 100

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

// Wei-Yu Chen 1, 2, * , Shih-Yang Liu 3, * , Yung-Sheng Chang 4 , Juan Juan Yin 5 , Hsiu-lien Yeh 6 , Tarek H. Mouhieddine 7 , Ola Hadadeh 7 , Wassim Abou-Kheir 7 , Yen-Nien Liu 4 1 Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan 2 Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan 3 Department of Acupuncture and Manipulation, College of International Education, Tianjin University of Traditional Chinese Medicine, Tianjin, China 4 Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan 5 Cell and Cancer Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. 6 Institute of Information System and Applications, National Tsing Hua University, HsinChu, Taiwan 7 Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon * These authors contributed equally to this work Correspondence to: Wassim Abou-Kheir, e-mail: wa12@aub.edu.lb Yen-Nien Liu, e-mail: liuy@tmu.edu.tw Keywords: Prostate cancer, bone metastasis, miR-34a, TCF7, BIRC5 Received: August 15, 2014 Accepted: November 02, 2014 Published: November 25, 2014 ABSTRACT Aberrant activation of Ras and WNT signaling are key events that have been shown to be up-regulated in prostate cancer that has metastasized to the bone. However, the regulatory mechanism of combinatorial Ras and WNT signaling in advanced prostate cancer is still unclear. TCF7 , a WNT signaling-related gene, has been implicated as a critical factor in bone metastasis, and here we show that TCF7 is a direct target of miR-34a. In samples of prostate cancer patients, miR-34a levels are inversely correlated with TCF7 expression and a WNT dependent gene signature. Ectopic miR-34a expression inhibited bone metastasis and reduced cancer cell proliferation in a Ras-dependent xenograft model. We demonstrate that miR-34a can directly interfere with the gene expression of the anti-proliferative BIRC5, by targeting BIRC5 3’UTR. Importantly, BIRC5 overexpression was sufficient to reconstitute anti-apoptotic signaling in cells expressing high levels of miR-34a. In prostate cancer patients, we found that BIRC5 levels were positively correlated with a Ras signaling signature expression. Our data show that the bone metastasis and anti-apoptotic effects found in Ras signaling-activated prostate cancer cells require miR-34a deficiency, which in turn aids in cell survival by activating the WNT and anti-apoptotic signaling pathways thereby inducing TCF7 and BIRC5 expressions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.2690

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

Metadata

Authors
Chen, W.-Y., Liu, S.-Y., Chang, Y.-S., Juan Yin, J., Yeh, H.-L., Mouhieddine, T. H., Hadadeh, O., Abou-Kheir, W., & Liu, Y.-N.
Venue
Oncotarget
Published
2014-11-25
Volume
6
Issue
1
Pages
441-457
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1576913910
Cited by
100
References
10
FWCI
3.30
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.